Predicting critical drug concentrations and torsadogenic risk using a multiscale exposure-response simulator.
暂无分享,去创建一个
Jiang Yao | Ellen Kuhl | Anna Sher | Francisco Sahli Costabal | E. Kuhl | F. Sahli Costabal | A. Sher | Jiang Yao
[1] J. Wong,et al. Generating fibre orientation maps in human heart models using Poisson interpolation , 2014, Computer methods in biomechanics and biomedical engineering.
[2] T. Hisada,et al. Screening system for drug-induced arrhythmogenic risk combining a patch clamp and heart simulator , 2015, Science Advances.
[3] David G Strauss,et al. Evolving regulatory paradigm for proarrhythmic risk assessment for new drugs. , 2016, Journal of electrocardiology.
[4] Jaimit Parikh,et al. Novel Two-Step Classifier for Torsades de Pointes Risk Stratification from Direct Features , 2017, Front. Pharmacol..
[5] E. Kuhl,et al. Predicting the cardiac toxicity of drugs using a novel multiscale exposure–response simulator , 2018, Computer methods in biomechanics and biomedical engineering.
[6] A. Garfinkel,et al. Early afterdepolarizations in cardiac myocytes: beyond reduced repolarization reserve. , 2013, Cardiovascular research.
[7] Yoram Rudy,et al. Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation , 2011, PLoS Comput. Biol..
[8] D. Durrer,et al. Total Excitation of the Isolated Human Heart , 1970, Circulation.
[9] Ellen Kuhl,et al. The importance of mechano-electrical feedback and inertia in cardiac electromechanics. , 2017, Computer methods in applied mechanics and engineering.
[10] L E Perotti,et al. Regional segmentation of ventricular models to achieve repolarization dispersion in cardiac electrophysiology modeling. , 2015, International journal for numerical methods in biomedical engineering.
[11] B. Lindsay,et al. Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter , 2015, Circulation. Arrhythmia and electrophysiology.
[12] G. Robertson,et al. HERG, a human inward rectifier in the voltage-gated potassium channel family. , 1995, Science.
[13] W. Saliba,et al. Dofetilide: a new class III antiarrhythmic agent , 2007, Expert review of cardiovascular therapy.
[14] G. Gintant,et al. Evolution of strategies to improve preclinical cardiac safety testing , 2016, Nature Reviews Drug Discovery.
[15] R. Califf,et al. Evaluation of the dofetilide risk-management program. , 2003, American heart journal.
[16] E. Sobie,et al. Improved Prediction of Drug‐Induced Torsades de Pointes Through Simulations of Dynamics and Machine Learning Algorithms , 2016, Clinical pharmacology and therapeutics.
[17] Denis Noble,et al. Contributions of HERG K+ current to repolarization of the human ventricular action potential. , 2008, Progress in biophysics and molecular biology.
[18] C Antzelevitch,et al. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes. , 1994, Journal of the American College of Cardiology.
[19] R Lazzara,et al. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. , 1996, Circulation.
[20] Alan Garfinkel,et al. So little source, so much sink: requirements for afterdepolarizations to propagate in tissue. , 2010, Biophysical journal.
[21] Kelly C. Chang,et al. Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-à-go-go-Related Gene) Channel–Drug Binding Kinetics and Multichannel Pharmacology , 2017, Circulation. Arrhythmia and electrophysiology.
[22] R. W. Hansen,et al. Journal of Health Economics , 2016 .
[23] T. Colatsky,et al. The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress. , 2016, Journal of pharmacological and toxicological methods.
[24] S. Göktepe,et al. Computational modeling of electrocardiograms: A finite element approach toward cardiac excitation , 2010 .
[25] J Vicente,et al. Differentiating Drug‐Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil , 2014, Clinical pharmacology and therapeutics.
[26] Trine Krogh-Madsen,et al. Global Optimization of Ventricular Myocyte Model to Multi-Variable Objective Improves Predictions of Drug-Induced Torsades de Pointes , 2017, Front. Physiol..
[27] D. Strauss,et al. An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel. , 2016, Journal of pharmacological and toxicological methods.
[28] Gary Gintant,et al. Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium. , 2014, American heart journal.
[29] P. Sager,et al. Mechanistic Model‐Informed Proarrhythmic Risk Assessment of Drugs: Review of the “CiPA” Initiative and Design of a Prospective Clinical Validation Study , 2017, Clinical pharmacology and therapeutics.
[30] Henggui Zhang,et al. Cardiac cell modelling: observations from the heart of the cardiac physiome project. , 2011, Progress in biophysics and molecular biology.
[31] Eric Kerfoot,et al. Verification of cardiac tissue electrophysiology simulators using an N-version benchmark , 2011, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[32] D. Fedida,et al. Probing the molecular basis of hERG drug block with unnatural amino acids , 2018, Scientific Reports.
[33] D. Noble,et al. A model for human ventricular tissue. , 2004, American journal of physiology. Heart and circulatory physiology.
[34] Edmund J. Crampin,et al. A global sensitivity tool for cardiac cell modeling: Application to ionic current balance and hypertrophic signaling , 2010, 2010 Annual International Conference of the IEEE Engineering in Medicine and Biology.
[35] Thomas L. Lenz,et al. Dofetilide, a New Class III Antiarrhythmic Agent , 2000, Pharmacotherapy.
[36] Jack Lee,et al. Multiphysics and multiscale modelling, data–model fusion and integration of organ physiology in the clinic: ventricular cardiac mechanics , 2016, Interface Focus.
[37] Euan A Ashley,et al. Early somatic mosaicism is a rare cause of long-QT syndrome , 2016, Proceedings of the National Academy of Sciences.
[38] Dulciana D. Chan,et al. Late sodium current block for drug‐induced long QT syndrome: Results from a prospective clinical trial , 2016, Clinical pharmacology and therapeutics.
[39] P. Taggart,et al. Early afterdepolarizations promote transmural reentry in ischemic human ventricles with reduced repolarization reserve , 2016, Progress in biophysics and molecular biology.
[40] Mitra Abbasi,et al. Early assessment of proarrhythmic risk of drugs using the in vitro data and single-cell-based in silico models: proof of concept , 2017, Toxicology mechanisms and methods.
[41] Jamie I Vandenberg,et al. Human ether-a-go-go related gene (hERG) K+ channels: function and dysfunction. , 2008, Progress in biophysics and molecular biology.
[42] Henggui Zhang,et al. hERG Inhibitors with Similar Potency But Different Binding Kinetics Do Not Pose the Same Proarrhythmic Risk: Implications for Drug Safety Assessment , 2014, Journal of cardiovascular electrophysiology.
[43] David F Briceño,et al. Dofetilide Reloaded: To Admit or Not to Admit, That is the Question. , 2017, Circulation. Arrhythmia and electrophysiology.
[44] Denis Noble,et al. Resolving the M-cell debate: why and how. , 2011, Heart rhythm.
[45] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[46] F Dessertenne,et al. [Ventricular tachycardia with 2 variable opposing foci]. , 1966, Archives des maladies du coeur et des vaisseaux.
[47] Jiang Yao,et al. Predicting drug‐induced arrhythmias by multiscale modeling , 2018, International journal for numerical methods in biomedical engineering.
[48] Alan Garny,et al. A numerical guide to the solution of the bi-domain equations of cardiac electrophysiology. , 2010, Progress in biophysics and molecular biology.
[49] D. Noble,et al. Mathematical models of the electrical action potential of Purkinje fibre cells , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[50] Ellen Kuhl,et al. The Living Heart Project: A robust and integrative simulator for human heart function. , 2014, European journal of mechanics. A, Solids.
[51] C. Antzelevitch,et al. Unique Topographical Distribution of M Cells Underlies Reentrant Mechanism of Torsade de Pointes in the Long-QT Syndrome , 2002, Circulation.
[52] Ellen Kuhl,et al. Interpreting Activation Mapping of Atrial Fibrillation: A Hybrid Computational/Physiological Study , 2018, Annals of Biomedical Engineering.
[53] Roderick MacKinnon,et al. Cryo-EM Structure of the Open Human Ether-à-go-go-Related K+ Channel hERG , 2017, Cell.
[54] Gary R. Mirams,et al. Evaluation of an in silico cardiac safety assay: Using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge , 2013, Journal of pharmacological and toxicological methods.
[55] Min Wu,et al. Uncertainty Quantification Reveals the Importance of Data Variability and Experimental Design Considerations for in Silico Proarrhythmia Risk Assessment , 2017, Front. Physiol..
[56] Gary R. Mirams,et al. Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic risk , 2011, Cardiovascular research.
[57] N P Smith,et al. Coupling multi-physics models to cardiac mechanics. , 2011, Progress in biophysics and molecular biology.
[58] David Gavaghan,et al. Multiscale cardiac modelling reveals the origins of notched T waves in long QT syndrome type 2 , 2014, Nature Communications.
[59] David Gavaghan,et al. A Bidomain Model of the Ventricular Specialized Conduction System of the Heart , 2012, SIAM J. Appl. Math..
[60] C Antzelevitch,et al. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. , 1991, Circulation research.
[61] Ellen Kuhl,et al. Generating Purkinje networks in the human heart. , 2016, Journal of biomechanics.
[62] N. Stockbridge,et al. Dealing with Global Safety Issues , 2013, Drug Safety.
[63] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[64] Nancy Wilkins-Diehr,et al. XSEDE: Accelerating Scientific Discovery , 2014, Computing in Science & Engineering.
[65] K. Sampson,et al. Molecular Pathophysiology of Congenital Long QT Syndrome. , 2017, Physiological reviews.
[66] D. Roden. Pharmacogenetics of Potassium Channel Blockers. , 2016, Cardiac electrophysiology clinics.
[67] A. Garfinkel,et al. Early afterdepolarizations and cardiac arrhythmias. , 2010, Heart rhythm.
[68] S. Göktepe,et al. Atrial and ventricular fibrillation: computational simulation of spiral waves in cardiac tissue , 2010 .
[69] Erik Grandelius. The bidomain equations of cardiac electrophysiology , 2017 .
[70] Donald M Bers,et al. Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays , 2013, Circulation.
[71] A. Camm,et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. , 2003, Cardiovascular research.
[72] S. Göktepe,et al. Computational modeling of cardiac electrophysiology: A novel finite element approach , 2009 .
[73] T. Hisada,et al. Transmural and apicobasal gradients in repolarization contribute to T-wave genesis in human surface ECG. , 2011, American journal of physiology. Heart and circulatory physiology.
[74] Oliver J. Britton,et al. Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity , 2017, Front. Physiol..
[75] R. W. Hansen,et al. The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.